9 records matched your query       

01994aam a2200385 a 4500
001 BC8BB4FCFE5F11E2B6A414D3DAD10320
003 SILO
005 20130806010419
006 m        d f      
007 cr bn|||||||||
008 100601s2010    dcua    sb   f000 0 eng c
035    $a (OCoLC)635577699
040    $a GPO $c GPO $d MvI $d SILO
042    $a pcc
043    $a n-us---
050 14 $a KF27 $b .J8568 2009e
074    $a 1020-C (online)
086 0  $a Y 4.J 89/1:111-73
088    $a Serial no. 111-73 (United States. Congress. House. Committee on the Judiciary)
110 1  $a United States. $b Subcommittee on Courts and Competition Policy. $b House. $b Committee on the Judiciary. $b Subcommittee on Courts and Competition Policy.
245 10 $a Biologics and biosimilars $h [electronic resource] : $b balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009.
260    $a Washington : $b U.S. G.P.O., $c 2010.
300    $a 1 online resource (iv, 252 p.) : $b ill.
500    $a Title from title screen (viewed on June 1, 2010).
504    $a Includes bibliographical references.
500    $a "Serial no. 111-73."
650  0 $a Drug development $x Government policy $z United States.
650  0 $a Pharmaceutical biotechnology $x Government policy $z United States.
650  0 $a Pharmaceutical biotechnology $z United States $v Patents.
650  0 $a Biologicals $x Government policy $z United States.
776 08 $i Print version: $a United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy. $t Biologics and biosimilars : $b balancing incentives for innovation $h iv, 252 p. $w (OCoLC)635495590
856 40 $u http://purl.access.gpo.gov/GPO/LPS122600
941    $a 1
952    $l USUX851 $d 20160825062952.0
956    $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=BC8BB4FCFE5F11E2B6A414D3DAD10320